Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Cancer Res Stat Treat. 2023 Dec 23;6(4):526–533. doi: 10.4103/crst.crst_93_23

Table 3. Correlates of comorbidities among patients with cancer.

Variables Yes (n=170),
n (%)
No (n=72), n (%) Adjusted Odds ratio (95% CI) P
Age (in years)
   31-50 28 (16.5) 30 (41.7) 1
   51-70 142 (83.5) 42 (58.3) 5.962 (2.844-12.500) <0.001*
Sex
   Male 70 (41.2) 24 (33.3) 1 0.108
   Female 100 (58.8) 48 (66.7) 0.526 (0.240-1.151)
Religion
   Hindu 95 (55.8) 30 (41.6) 1 0.312
   Others$ 75 (44.1) 42 (58.3) 0.707 (0.361-1.385)
Family history of comorbidities
   Yes 123 (72.3) 38 (52.7) 1 <0.001*
   No 47 (27.6) 34 (47.2) 0.234 (0.107-0.508)
Body Mass Index (BMI)
   Normal weight and below 117 (68.8) 39 (54.2) 2.847 (1.260-6.432) 0.012
   Overweight and above  53 (31.2) 33 (45.8) Ref
Treatment duration
   ≤6 months 21 (12.4) 28 (38.9) 1 <0.001*
   >6 months 147 (87.6) 44 (61.1) 4.058 (1.769-9.305)
$

Others includes Christians and Muslims,

*

denotes statistically significant P